Curated podcasts, conversations, and research — organized so you can go as deep as you want.
A board-certified physician walks through GLP-1 analogs, BPC-157, growth hormone peptides, NAD supplementation, and sourcing considerations. One of the most comprehensive and accessible conversations on peptide therapy available.
Almost nobody actually understands peptides. This episode fixes that — covering BPC-157, TB-500, GLP-1s, receptor mechanisms, and the regulatory landscape around compounding pharmacies.
Exercise, Nutrition, Hormones for Vitality & Longevity
BPC-157 and Peptide Stacks
One of the most intellectually honest framings in the public record on using peptides as part of a structured protocol — not as a replacement for proven interventions, but as a carefully evaluated addition.
Gastric pentadecapeptide BPC-157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocyte growth
— Journal of Orthopaedic Research
BPC-157 and its role in accelerating musculoskeletal soft tissue healing
Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis
— Nutrition & Metabolism, 2022
TRIUMPH-1 trial (Eli Lilly, May 2026) — triple receptor agonist efficacy and body composition outcomes
Some compounds in our catalog have robust clinical trial data. Others have strong animal model evidence and growing human anecdotal support, but are still awaiting large-scale human trials. We distinguish between the two — and we’ll always tell you which is which.
If the science isn’t there, the product isn’t here.